Temporal lobe epilepsy (TLE) is a neurological disorder affecting millions of people worldwide and currently represents the most common form of focal epilepsy. Thus, the …
B Wang, Q Li, H Wang, X Du, Q Lai, X Li… - Journal of Clinical …, 2024 - Elsevier
Objective By analysing the difference in TNF-α levels in the peripheral blood of patients with medial temporal lobe epilepsy (mTLE) with or without hippocampal sclerosis and the …
X Yang, X Zhang, K Shen, Z Wang, G Liu… - Frontiers in …, 2023 - frontiersin.org
Introduction: Temporal lobe epilepsy (TLE) is the most common subtype of epilepsy in adults and is characterized by neuronal loss, gliosis, and sprouting mossy fibers in the …
Q Zhang, J Liu, L Chen, M Zhang - Molecular Neurobiology, 2023 - Springer
Alzheimer's disease (AD) is the most universal neurodegenerative disorder characterized by memory loss and cognitive impairment. AD is biologically defined by production and …
X Kuang, S Chen, Q Ye - Current Molecular Medicine, 2024 - ingentaconnect.com
Epilepsy is one of the most common brain disorders that not only causes death worldwide, but also affects the daily lives of patients. Previous studies have revealed that inflammation …
H Chu, J Dong, Y Tang, C Huang, Q Guo - Neurotoxicity Research, 2023 - Springer
We aimed to test the effects of connexin43 (Cx43) on ischemic neurogenesis and examined whether it was dependent on aquaporin-4 (AQP4). We detected the expression of Cx43 and …
Q Li, Z Qu, L Jia, W Wang - Epilepsy Research, 2024 - Elsevier
Background The NOD-like receptor family, pyrin domain-containing 3 (NLRP3) inflammatory pathway is implicated in the development of epilepsy and can be suppressed by the …
D Li, X Zhang, R Liu, M Long, S Zhou, J Lin, L Zhang - NeuroToxicology, 2023 - Elsevier
Objective To explore the relationship between the proinflammatory factor high‐mobility group box 1 (HMGB1) and glutamatergic alpha-amino-3-hydroxy-5-methyl-4 …
JMC Brown, M Zaben, C Ormonde, F Sharouf… - Biochemical …, 2023 - Elsevier
Glioblastoma is among the most lethal cancers, with no known cure. A multitude of therapeutics are being developed or in clinical trials, but currently there are no ways to …